Company profilePharmaceutical#808 of 1,318 in Pakistan✓ No DRAP alerts

SHAHZAIB PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 9 brands · 16 molecules

Ranked #6 of 11 companies in Solutions Affecting The Electrolyte Balance

9 registered products 23 pharmaceutical brands 16 distinct molecules 0 DRAP alerts

Company overview

9
registered products
23
pharmaceutical brands
16
distinct molecules
3
therapeutic classes
0
DRAP alerts

SHAHZAIB PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 9 product registrations across 16 distinct molecules. Its portfolio is concentrated in Solutions Affecting The Electrolyte Balance and Solutions For Parenteral Nutrition. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Dextrose 5%2 brands
Dextrose Iv Solution1 brand
Ringers1 brand
Calcium1 brand
Ringers Infusion1 brand

Therapeutic classes

Solutions Affecting The Electrolyte Balance · 6Solutions For Parenteral Nutrition · 1Solutions Producing Osmotic Diuresis · 1

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Otsuka Pakistan Limited14 shared molecules
Medipak (Pvt) Ltd14 shared molecules
SEARLE IV SOLUTION13 shared molecules
GEOFMAN PHARMACEUTICALS12 shared molecules
FRONTIER DEXTROSE LIMITED12 shared molecules
GALLOP8 shared molecules
SEARLE PAKISTAN (PVT.) LTD.7 shared molecules

Get the full profile for SHAHZAIB

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.